Document Detail


Potential ergogenic effects of arginine and creatine supplementation.
MedLine Citation:
PMID:  15465806     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
The rationale for the use of nutritional supplements to enhance exercise capacity is based on the assumption that they will confer an ergogenic effect above and beyond that afforded by regular food ingestion alone. The proposed or advertised ergogenic effect of many supplements is based on a presumptive metabolic pathway and may not necessarily translate to quantifiable changes in a variable as broadly defined as exercise performance. L-arginine is a conditionally essential amino acid that has received considerable attention due to potential effects on growth hormone secretion and nitric oxide production. In some clinical circumstances (e.g., burn injury, sepsis) in which the demand for arginine cannot be fully met by de novo synthesis and normal dietary intake, exogenous arginine has been shown to facilitate the maintenance of lean body mass and functional capacity. However, the evidence that supplemental arginine may also confer an ergogenic effect in normal healthy individuals is less compelling. In contrast to arginine, numerous studies have reported that supplementation with the arginine metabolite creatine facilitates an increase in anaerobic work capacity and muscle mass when accompanied by resistance training programs in both normal and patient populations. Whereas improvement in the rate of phosphocreatine resynthesis is largely responsible for improvements in acute work capacity, the direct effect of creatine supplementation on skeletal muscle protein synthesis is less clear. The purpose of this review is to summarize the role of arginine and its metabolite creatine in the context of a nutrition supplement for use in conjunction with an exercise stimulus in both healthy and patient populations.
Authors:
Douglas Paddon-Jones; Elisabet Børsheim; Robert R Wolfe
Related Documents :
12237976 - Training-induced alterations of the fatty acid profile of rabbit muscles.
18239076 - Muscle-specific expression of ppargamma coactivator-1alpha improves exercise performanc...
3316916 - Protein degradation during endurance exercise and recovery.
20720176 - Muscle protein synthesis and gene expression during recovery from aerobic exercise in t...
1763296 - Scintigraphic determination of gastrointestinal transit times. a comparison with breath...
10593646 - Acute aerobic exercise and affect: current status, problems and prospects regarding dos...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, U.S. Gov't, P.H.S.; Review    
Journal Detail:
Title:  The Journal of nutrition     Volume:  134     ISSN:  0022-3166     ISO Abbreviation:  J. Nutr.     Publication Date:  2004 Oct 
Date Detail:
Created Date:  2004-10-06     Completed Date:  2004-11-23     Revised Date:  2007-11-14    
Medline Journal Info:
Nlm Unique ID:  0404243     Medline TA:  J Nutr     Country:  United States    
Other Details:
Languages:  eng     Pagination:  2888S-2894S; discussion 2895S     Citation Subset:  IM; S    
Affiliation:
Department of Surgery, The University of Texas Medical Branch and Metabolism Unit, Shriners Hospitals for Children, Galveston, TX 77550, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Arginine / pharmacology*
Creatine / pharmacology*
Dietary Supplements*
Energy Metabolism / drug effects*
Humans
Physical Endurance / drug effects*
Grant Support
ID/Acronym/Agency:
5 R01 GM 57295/GM/NIGMS NIH HHS
Chemical
Reg. No./Substance:
57-00-1/Creatine; 74-79-3/Arginine
Investigator
Investigator/Affiliation:
R R Wolfe / U TX Med Br, Galveston

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Arginine and endothelial and vascular health.
Next Document:  Specificity of prion assembly in vivo. [PSI+] and [PIN+] form separate structures in yeast.